The current institutional shareholding score of Intellia Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 86.89%, representing a quarter-over-quarter decrease of 4.63%. The largest institutional shareholder is Catherine Wood, holding a total of 13.84M shares, representing 12.05% of shares outstanding, with 16.04% increase in holdings.